Medicamen Biotech Limited — Important, 08-04-2025: Updates

Medicamen Biotech Limited has submitted its annual disclosures as required under SEBI regulations for substantial acquisition of shares and takeovers for the financial year ending March 31, 2025. These disclosures from the Promoters and Promoter group will also be available on the company’s website. This aligns with compliance obligations and enhances transparency regarding shareholding changes, which could impact investor confidence and perception of the company's governance practices. Stakeholders should monitor this development closely for any potential implications on shareholder structure.